The promotional effort from Ferring features bladder cancer survivors sharing the news of a new treatment option.

In a report released on March 17, Nicolas Pauillac from Kepler Capital maintained a Buy rating on COSMO Pharmaceuticals N.V. (0RGI – Research Report), with a price target of CHF84.00.

Tonix Pharmaceuticals (TNXP) announced it has been awarded a grant from the Medical CBRN Defense Consortium, MCDC, to support the development of TNX-801. MCDC is a consortium of industrial ...

added Brian Clark, Vice President, Global Medical Head of Gastro-Enterology Therapeutic Area, Global Research and Medical, Ferring.

Thank you for signing up! Did you know with an ad-lite subscription to SussexWorld, you get 70% fewer ads while viewing the news that matters to you. Sorry, there ...

diff Infection Ferring's novel first-in-class REBYOTA is indicated for the prevention of recurrence of Clostridioides difficile infection (C. diff) in individuals 18 years of age and older ...

DUBLIN and DURHAM, N.C., March 5, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) ("Jazz" or the "Company") and Chimerix (Nasdaq: CMRX) ("Chimerix ...

March 5 (Reuters) - Merck's (MRK.N), opens new tab injected version of its blockbuster cancer drug Keytruda could face a potential patent challenge from biotech Halozyme Therapeutics (HALO.O ...

Workday leaders provide additional insights, and there is a short case study from Ferring Pharmaceuticals, which adopted a culture of continuous learning and development. The section looks at the ...